REGENXBIO Inc. appointed Mitchell Chan as the new Chief Financial Officer, replacing Vittal Vasista, who resigned after over 15 years; Chan's salary is $490,000 with a $3 million stock option grant, while Vasista will receive a $500,018 separation allowance and advisory role until January 2025.